Tell us about Modi Medicare’s offerings for the healthcare sector?
|
Jigish B Modi
|
Modi Medicare has unique range of radiology workstation products to address the needs of radiologists and surgeons, especially in surgical planning of liver and brain, which has been widely accepted. These products are well renowned Intrasense Myrian range of radiology workstations which are modular and scalable. We also offer Angiodynamics RITA radiofrequency ablation products for addressing the needs of surgical oncologists and interventional radiologists for the last 12 years. We have successfully established a protocol for solitary tumour ablation in liver as well as osteoid osteoma.
Which offerings by Modi Medicare have gained popularity and acceptance in the past few years?
Myrian is the first true multi-modality workstation in the market with the capacity to combine, compare and process images from several modalities simultaneously. Myrian also adapts itself to the exact needs of each user and hospital. Liver transplant has been growing in India. Liver resections are also getting very precise which helps the surgeons to save precious lives. To address such specific needs, we offer Myrian Liver solution which is very popular because of its accuracy and precise volumetric outputs which radiologists and surgeons have well appreciated. Liver surgeons also have the need to know the exact anatomical landmarks for precise surgery. This has led to increased popularity for our products. Our Myrian XT-brain which has complete solution for DTI,fMRI and perfusion is also well appreciated. Myrian also has comprehensive disease follow-up programmes in oncology, COPD, etc…. which gives the end-user a complete exhaustive, sophisticated, yet user-friendly solutions which can be established as a PAN-Hospital solution.
How has the company grown since its inception?
Modi Medicare has been involved in the Indian market for radiology workstations for more than four years. We have implemented Myrian installations in several major tier I and tier II cities (Mumbai, Delhi, Chennai, Ahmedabad, Vadodara, Hyderabad, Lucknow, Kozhikode, and Thiruvananthapuram). Our existing references include leading organisations comprising public hospitals, medical colleges and private institutions and clinics. Today, India represents our biggest installed base and market opportunities for South Asia Pacific area. We now have a dedicated team based at several locations in order to follow the client’s needs and timely address their technical, clinical and commercial needs.
What are the company’s plans for this segment in the coming fiscal?
In the next fiscal, we will try to consolidate our strengths and introduce ourselves. Our platform is very well accepted in the global market and regarded as a competitive alternative or complement to modality vendors’ workstations as well as a smart way to enhance existing PACS installations. With three major product launches every year, we move fast to offer state-of-the-art technology to our users. Myrian XL-ONCO for cancer therapy evaluation or Myrian XP-LIVER for liver surgery planning are considered as the best solutions in their categories. The company recently launched Myrian XP-BREAST, the most advanced breast MRI viewer on the market, and Myian XP-Prostrate, with outstanding reading performance, smart clinical workflows and post-processing features. Combined with high quality services, these solutions will drive our domestic growth and market leadership as the most innovative visualisation software in radiology field.
What are the advantages and challenges in India for Modi Medicare?
Insurance companies are playing a major role in the development of healthcare system. This has led to strong drivers of growth: increase in healthcare spending, changes in demography and lifestyle, and significant increase of medical tourism. We strongly consider India as a high potential market. Indeed, the opportunity perspectives are becoming wider with PACS companies who need advanced visualisation and post-treatment software to replace or upgrade their existing system, CT and MRI modality vendors who want to complement their own workstation with high-end expert modules (eg: brain and cardiac analysis) or finally refurbishing companies who are looking for a competitive offer to match their requirements.
What has been Modi Medicare’s role in Indian imaging market’s evolution?
The overall response from the Indian market towards Myrian remains very good. At the beginning, this response was more oriented on very specific needs, for example in terms of post-processing diagnosis mainly dedicated to liver surgery (transplant programs, digestive surgery). Now, it seems that the market demand will also shape up in the future months and year, with new policies to combat chronic diseases (respiratory diseases, diabetes) and in the field on oncology. Three major characteristics will make Myrian the perfect solution to address all the above needs: comprehensive organ-based applications, vendor-neutral multi-modality platform, disease management and follow up.